JAZZ Financial Facts
Total revenues: 73.29MTotal operating expenses: 39.59M
See Full Income Statement
Other current assets: 532K
Other long-term assets: 83K
See Full Balance Sheet
Jazz Pharmaceuticals, Inc. (JAZZ) Earnings
|
Expand Research on JAZZ
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +13.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/9/22 | Q222 | N/A | $4.19 | N/A | N/A | $900.71M | N/A | N/A | N/A | ||
| 5/4/22 |  |
Q122 | $3.73 | $3.84 | -$0.11 | $813.7M | $852.75M | N/A |  | | Details |
| 3/1/22 | |
Q421 | $4.21 | $3.63 | +$0.58 | $892.88M | $865.88M | N/A | | | Details |
| 11/9/21 | |
Q321 | $4.20 | $3.31 | +$0.89 | $838.1M | $832.52M | N/A | | | Details |
| 8/3/21 | |
Q221 | $3.90 | $3.42 | +$0.48 | $751.8M | $735.62M | N/A | | | Details |
| 5/4/21 | |
Q121 | $3.92 | $3.71 | +$0.21 | $607.58M | $608.24M | N/A | | | Details |
| 2/23/21 | |
Q420 | $4.00 | $4.20 | -$0.20 | $665.5M | $639.55M | N/A | | | Details |
| 11/2/20 | |
Q320 | $4.31 | $4.08 | +$0.23 | $600.89M | $577.58M | N/A | | | Details |
